Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PROCEPT BioRobotics's share price for the quarter that ended in Mar. 2024 was $49.42. PROCEPT BioRobotics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 51.4 Mil. Therefore, PROCEPT BioRobotics's market cap for the quarter that ended in Mar. 2024 was $2,539.8 Mil.
PROCEPT BioRobotics's quarterly market cap
increased
from Sep. 2023 ($1,656.0 Mil) to Dec. 2023 ($2,127.8 Mil) and
increased
from Dec. 2023 ($2,127.8 Mil) to Mar. 2024 ($2,539.8 Mil).
PROCEPT BioRobotics's annual market cap
increased
from Dec. 2021 ($1,092.3 Mil) to Dec. 2022 ($1,862.2 Mil) and
increased
from Dec. 2022 ($1,862.2 Mil) to Dec. 2023 ($2,127.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PROCEPT BioRobotics's Enterprise Value for Today is $3,226.2 Mil.
PROCEPT BioRobotics Market Cap Historical Data
The historical data trend for PROCEPT BioRobotics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PROCEPT BioRobotics's Market Cap
For the Medical Devices subindustry, PROCEPT BioRobotics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PROCEPT BioRobotics's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PROCEPT BioRobotics's Market Cap distribution charts can be found below:
* The bar in red indicates where PROCEPT BioRobotics's Market Cap falls into.
PROCEPT BioRobotics Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PROCEPT BioRobotics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PROCEPT BioRobotics (NAS:PRCT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PROCEPT BioRobotics Market Cap Related Terms
Thank you for viewing the detailed overview of PROCEPT BioRobotics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
PROCEPT BioRobotics (PROCEPT BioRobotics) Business Description
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRCT has been successfully added to your 